Lundbeck Psychiatry Nurse Education Forum 2025

In its 5th year, the Lundbeck Psychiatry Nurse Education Forum was initiated in 2021 with the intent of creating an excellent educational event for nurses working in psychiatry in both community and hospital settings in Ireland, to complement other educational offerings currently available.

Each year the agenda and topics are decided by a steering committee of experienced and motivated nurses working in psychiatry. The first meeting was created as a virtual event in 2021 and is now an in-person event  attracting an audience from all over Ireland.

Nurses attending these meetings have the opportunity to network with nurses in similar roles, acquire useful knowledge that educates themselves and their peers, ultimately improving patient outcomes. This year we expect the highest attendance yet with speakers addressing current challenges facing nurses working in psychiatry today.

This promotional medical education meeting has been organised and financially sponsored by Lundbeck Ireland Ltd.

Prescribing information for Abilify Maintena (aripiprazole)  is available on: Medicines.ie [accessed March 2025]

Further Information available upon request

IE-ASMT-0080
Date of preparation: April 2025

  • Job bag number: IE-ASMT-0080
  • Date of preparation: April 2025
  • ABBREVIATED PRESCRIBING INFORMATION ABILIFY MAINTENA® (aripiprazole) POWDER AND SOLVENT FOR PROLONGED-RELEASE SUSPENSION FOR INJECTION ABILIFY MAINTENA® POWDER AND SOLVENT FOR PROLONGED-RELEASE SUSPENSION FOR INJECTION IN PRE-FILLED SYRINGE. Please refer to the Summary of Product Characteristics (SmPC) before prescribing. PRESENTATIONS: Powder and solvent for prolonged-release suspension for injection: Vial with 400mg aripiprazole. Powder and solvent for prolonged-release suspension for injection in pre-filled syringe: Pre-filled syringe with 400mg aripiprazole. Prolonged-release suspension for injection in pre-filled syringe: Pre-filled syringe with 720mg aripiprazole; Pre-filled syringe with 960mg aripiprazole. INDICATION: Maintenance treatment of schizophrenia in adult patients stabilised with oral aripiprazole. DOSAGE AND ADMINISTRATION: For patients who have never taken aripiprazole, tolerability with oral aripiprazole must occur prior to initiation. Titration of the dose for Abilify Maintena is not required. For patients transitioning from 400mg once monthly, the 960mg is recommended no sooner than 26 days after previous injection of 400mg, and every 2 months (56 days) thereafter. Starting dose can be administered as one injection start or as two injection start. One injection start: Following oral therapy, one injection of Abilify Maintena® 400mg or 960mg should be administered. Continue daily treatment with 10mg to 20mg oral aripiprazole for 14 consecutive days to maintain therapeutic aripiprazole concentration during initiation of therapy. Two injection start for 400mg: Two separate injections of Abilify Maintena® 400mg should be administered at two different injection sites, along with one 20mg dose of oral aripiprazole. Maintenance: After either the one or the two injection start with Abilify Maintena® 400mg, the recommended maintenance dose of Abilify Maintena® is 400mg once monthly as a single injection (no sooner than 26 days after the previous injection). Consider dose reduction if adverse reactions experienced. See SmPC for further details. Two injection start for 960mg: Following oral therapy, one injection of Abilify Maintena® 960mg and one injection of Abilify Maintena® 400mg should be administered at two different injection sites (see method of administration), along with one 20mg dose of oral aripiprazole. Maintenance: After one or two 960mg injection start, the recommended maintenance dose is one injection of Abilify Maintena® 960mg every second month (once every two months as a single injection 56 days after the previous injection). Consider reducing the dose to 720mg once every two months if adverse reactions experienced. See SmPC for further details. Method of Administration: Intramuscular injection. Suspension should be injected slowly as a single injection (doses must not be divided) into gluteal or deltoid muscle (care should be taken to avoid inadvertent injection into a blood vessel). DO NOT inject two injections concomitantly into the same deltoid or gluteal muscle. 960mg/720mg: For gluteal intramuscular injection only (alternate between right and left side). 400mg: For known CYP2D6 poor metabolisers administer in either two separate deltoid muscles, or one deltoid and one gluteal muscle. DO NOT inject into two gluteal muscles. Special populations: Hepatic impairment: No dose adjustment required for mild-moderate hepatic impairment. Manage dose cautiously in severe hepatic impairment. Oral formulation should be preferred. Renal impairment: No dose adjustment required. Elderly: Safety and efficacy not established in patients ≥65 years old. Paediatrics: Safety and efficacy in children and adolescents aged 0-17 not established. For advice on use with known CYP2D6 poor metabolisers, or concomitant use with CYP3A4 inhibitors/inducers or CYP2D6 inhibitors, see SmPC. See SmPC for instructions on missed doses, reconstitution and injection procedure. CONTRAINDICATIONS: Hypersensitivity to active substance or excipients. WARNINGS AND PRECAUTIONS: During antipsychotic treatment, improvement in clinical condition may take days to weeks – monitor closely. Abilify Maintena should not be used to manage acutely agitated or severely psychotic states when immediate symptom control is warranted. Suicidality: Reported early after initiation or switch of antipsychotic treatment – closely supervise high risk patients. Cardiovascular disorders: Use with caution in patients with known cardiovascular disease, cerebrovascular disease, conditions which would predispose patients to hypotension or hypertension, including accelerated or malignant. Cases of venous thromboembolism (VTE) have been reported with antipsychotics. All possible VTE risk factors should be identified before and during treatment and preventive measures taken. QT prolongation: Use with caution in patients with a family history of QT prolongation. Tardive dyskinesia: Discontinuation or dose reduction should be considered if patient experiences signs/symptoms of tardive dyskinesia. Symptoms can temporally deteriorate or even arise after treatment discontinuation. Neuroleptic malignant syndrome (NMS): Rare cases reported during clinical trials. If patient develops signs and symptoms indicative of NMS or unexplained high fever without additional clinical manifestations of NMS, all antipsychotics, including aripiprazole, must be discontinued. Seizure: Use with caution in patients who have a history of seizure disorder or have conditions associated with seizures. Elderly patients with dementia-related psychosis: Not indicated for treatment of patients with dementia-related psychosis. Hyperglycaemia and diabetes mellitus: Hyperglycaemia, in some cases extreme and associated with ketoacidosis or hyperosmolar coma or death, have been reported. Observe for signs and symptoms of hyperglycaemia and monitor diabetes mellitus patients, or those at risk of diabetes mellitus, regularly for worsening glucose control. Hypersensitivity: Hypersensitivity reactions may occur. Weight gain: Has been reported post-marketing with oral aripiprazole, usually in those with significant risk factors . Dysphagia: Use with caution in patients at risk for aspiration pneumonia. Oesophageal dysmotility and aspiration have been associated with the use of aripiprazole. Gambling disorder and other impulse control disorders: Increased urges can be experienced while taking aripiprazole, and inability to control urges e.g. gambling, sexual urges, compulsive shopping, binge or compulsive eating. Patients or caregivers should be asked about development of new or increased urges. If urges develop during treatment, consider dose reduction or treatment cessation. Falls: May cause somnolence, postural hypotension, motor and sensory instability, which may lead to falls. Caution should be taken when treating patients at higher risk (e.g., elderly or debilitated patients), and a lower starting dose should be considered. Sodium: Abilify Maintena contains sodium (<1 mmol/dose). INTERACTIONS: Aripiprazole has potential to enhance effect of certain antihypertensives. Caution when administering with alcohol or CNS medicines with overlapping effects such as sedation. Caution if administered with medicines known to cause QT prolongation or electrolyte imbalance. Monitor for serotonin syndrome if aripiprazole is used concomitantly with serotonergic medicines such as Selective Serotonin Reuptake Inhibitors (SSRI)/ Serotonin-Norepinephrine Reuptake Inhibitors (SNRI) or medicines known to increase aripiprazole concentrations. Concomitant use of CYP3A4 inducers with Abilify Maintena should be avoided. For advice on use with CYP2D6 inhibitors or CYP3A4 inhibitors or inducers see SmPC. ABILITY TO DRIVE AND USE MACHINES: Minor to moderate influence on the ability to drive and use machines due to potential nervous system and visual effects, such as sedation, somnolence, syncope, vision blurred, diplopia. FERTILITY, PREGNANCY AND LACTATION: Should not be used in pregnancy, or in women planning to become pregnant, unless clearly necessary. Neonates exposed to antipsychotics during third trimester of pregnancy at risk of reactions including extrapyramidal and/or withdrawal symptoms: monitor carefully. Aripiprazole/metabolites are excreted in breast milk. Patients currently under treatment or who have been treated in the past 34 weeks should not breast feed. OVERDOSE: Supportive therapy, maintain an adequate airway, oxygenation and ventilation, management of symptoms with cardiovascular monitoring, including continuous electrocardiographic monitoring with close medical supervision and monitoring. UNDESIRABLE EFFECTS: Refer to Section 4.8 of the SPC for complete information on side effects. Common (≥1/100 to <1/10): Weight increaseda , diabetes mellitus, weight decreased, agitation, anxiety, restlessness, insomnia, extrapyramidal disorder, akathisia, tremor, dyskinesia, sedation, somnolence, dizziness, headache, dry mouth, musculoskeletal stiffness, erectile dysfunction, injection site paina, injection site induration, fatigue, blood creatine phosphokinase increased. a Reported as very common in Abilify Maintena 960mg/720mg clinical trials. LEGAL CATEGORY: Prescription Only Medicine (POM) MARKETING AUTHORISATION (MA) NUMBERS: Abilify Maintena® powder and solvent for prolonged-release suspension for injection: Single pack vial of 400mg powder, 2mL vial of solvent and syringes, (EU/1/13/882/002); Single pack of pre-filled syringe of 400mg, (EU/1/13/882/006); Single pack of pre-filled syringe of 960mg, (EU/1/13/882/010). MA HOLDER: Otsuka Pharmaceutical Netherlands B.V, Herikerbergweg 292, 1101 CT, Amsterdam, The Netherlands. FURTHER INFORMATION AVAILABLE ON REQUEST FROM: Lundbeck Ireland Ltd, 4045 Kingswood Road, Citywest Business Park, Co Dublin. Tel. 01 4689800 DATE OF REVISION: June 2025 REFERENCE: IE-ABIM-0350

  • Adverse events should be reported. Reporting forms and information can be found at www.hpra.ie. Adverse events should also be reported to Lundbeck (Ireland) Ltd on: 01 4689800 or by email to: SafetyLuIreland@lundbeck.com

Hourly Schedule

NEF 2025

9:45 - 10:15
Arrival & Registration
10.15 - 10:30
Chairperson Opening Remarks
Speakers:
Mr Michael Hevey
10.30 - 11:15
A Window of Opportunity - Early Intervention in Psychosis
Speakers:
Ms. Elizabeth Wycherley
11.15 - 12:00
CNS Experience of Abilify Maintena in a Community Setting
Speakers:
Ms. SInead Fahy
12:00 - 13:00
Lunch
13:00 - 13:45
Physical Health in Mental Health - Back To Basics
Speakers:
Ms. Helen Cocoman
13:45 - 14:30
Challenging Imposter Syndrome
Speakers:
Ms. Shelley Crawford
14:30 - 14.45
Questions & Answers
Speakers:
Mr Michael Hevey, Ms. Elizabeth Wycherley, Ms. Helen Cocoman, Ms. Shelley Crawford, Ms. SInead Fahy
14.45
Meeting Close
Mr Michael Hevey
Mr Michael Hevey
Advanced Nurse Practitioner
Michael Hevey is an Advanced Nurse Practitioner in Inclusion Mental Health at Dublin South City Mental Health Service/ St. James’s Hospital. Inclusion Health is a relatively modern term used to identify people who have traditionally been socially excluded from mainstream healthcare and have experienced factors that have contributed to poor health, such as poverty, violence, and complex trauma (Luchenski et al. 2018). Most often, those excluded are homeless people, individuals with drug and alcohol addiction, members of Traveller, Roma and Gypsy communities, sex workers, migrant populations, people who have been trafficked for slavery, people who have had contact with the criminal justice system, and members of the LGBTQ+ community. Prior to his appointment to the ANP in 2023, Michael has served as a Community Mental Health Nurse since 2001 within the Dublin South Central Mental Health Service. He finalized his psychiatric nursing training at St. Patrick’s Hospital in 1995 and subsequently earned a Bachelor of Arts in Industrial Relations and Personnel Management from the National College of Ireland in 2003. Michael attained a Master of Science degree in Nursing (Applied Healthcare Management) from University College Dublin in 2011. In 2018, he graduated with a Professional Diploma in Prescription of Medication from University College Dublin, and in 2019, he completed the Graduate Certificate in Advanced Nursing Practice, also from University College Dublin. In 2022, Michael, together with Dr. Eileen Sweeney, Consultant Psychiatrist at the DSCMHS, and Professor Ní Cheallaigh, established the Inclusion Health Research Forum at St. James’s Hospital. This initiative aims to bring together clinicians and academics from the Hospital, as well as other healthcare providers and educational institutions. Michael serves as a preceptor for undergraduate nursing students during their clinical placements. Additionally, he delivers lectures to both undergraduate nursing and medical students, as well as graduate nursing students at University College Dublin and Trinity College Dublin. In 2020, Michael was appointed as an Adjunct Lecturer/ Assistant Professor at the University College Dublin School of Nursing, Midwifery, and Health Systems (UCDSNMHS). In this capacity, he actively participates in the education of both undergraduate and postgraduate students. A significant aspect of his responsibilities at UCDSNMHS involves facilitating student workshops on the Advanced Health Assessment Module, Integrated Care Module, Clinical Decision-Making Module, and Clinical Practicum Module. Michael began his doctoral studies at UCDSNMHS in January 2022 and was awarded a PhD scholarship in September 2022. In August 2022, Michael presented at the ICN Nurse Practitioners/Advanced Nurse Practitioner Conference on student Nurse Practitioners’ perceptions of fundamental care. In September of the same year, he presented at the Nursing & Midwifery Planning & Development Unit Dublin South, Kildare, and Wicklow’s 7th Annual Regional Conference on ‘Inclusion Health Nurses—Overcoming Barriers’. Michael was a keynote speaker at a conference in Lisbon in 2023 on ‘Community Mental Health Care in Ireland—Evolving Nursing Roles’ at the Seminário de Enfermagem de Saúde Mental: Lisboa. In 2024, Michael presented at the Dublin and Midlands Nursing and Midwifery Conference, where he won the award for Best Oral Presentation for his talk on establishing and developing an Advanced Nurse Practitioner role in Inclusion Mental Health.
Ms. Elizabeth Wycherley
Ms. Elizabeth Wycherley
Advanced Nurse Practitioner
Elizabeth Wycherley is a Registered Advanced Nurse Practitioner in Early Intervention in Psychosis since 2019. She was a driving force in the initiation of an Early Intervention in Psychosis service in North Lee Mental Health Service in Cork, established in 2012. Elizabeth is now working with the RISE Team, one of the National Clinical Programmes Demonstration Sites in South Lee Mental Health Services also in Cork.
Ms. SInead Fahy
Ms. SInead Fahy
Community Mental Health Nurse
Sinead Fahy McCarthy is a dedicated and highly experienced psychiatric nurse with over two decades of expertise in mental health care. She began her professional journey in 2002 after successfully training and qualifying as a psychiatric nurse. Her early career saw her working in rehabilitation units, where she provided essential support to individuals undergoing long-term recovery. In 2003, she transitioned to acute mental health units, gaining extensive experience working with adults in both male and female wards, dealing with complex and acute psychiatric conditions. In 2004, Sinead took a pivotal step in her career by moving into community-based mental health services. She played a key role in the establishment of the first Home-Based Treatment Team in Tallaght, working alongside colleagues to develop an alternative to hospital admissions for individuals in crisis. This innovative approach focused on providing intensive, short-term interventions in a patient’s home environment, promoting stability and recovery while reducing the need for inpatient care. Throughout her career, Sinead has continuously pursued professional development to enhance her expertise. In 2009, she completed a specialized course on eating disorders at the University of Ulster, expanding her knowledge of the complexities surrounding these conditions. Recognizing the importance of evidence-based therapies, she obtained a Certificate in Cognitive Behavioural Therapy (CBT) through the Health Service Executive (HSE), equipping her with the skills to provide structured psychological interventions to those experiencing anxiety, depression, and other mental health challenges. In 2014, she furthered her qualifications by completing a Nurse Prescribing Course with the Royal College of Surgeons in Ireland (RCSI), allowing her to take on an advanced role in medication management within psychiatric care. Committed to continuous learning and the integration of cutting-edge psychological approaches, Sinead is currently undertaking a course in Coaching and Neuroscience. This additional training is aimed at broadening her expertise in mental health support, leadership, and personal development, reinforcing her holistic approach to patient care. Sinead’s professional journey reflects her deep passion for mental health nursing, her commitment to patient-centered care, and her dedication to advancing the field through ongoing education and innovation.
Ms. Helen Cocoman
Ms. Helen Cocoman
Advanced Nurse Practitioner (cand)
Helen trained in Trinity College Dublin, she qualified as Registered Psychiatric Nurse in 2008. She worked in Acute/Community and Rural outback of Australia caring for multicultural mental health patients. She returned to Ireland in 2015 and worked in inpatient and adult community mental teams as an A/CNS. She completed a post graduate diploma in University of Limerick. She then worked as CNS in physical health in the Kildare mental health service and now is a candidate Advanced Nurse Practitioner in Physical Health in Tallaght mental health services. She has always had a strong passion for the physical health of our mental health patients and making every contact count in her nursing assessments & interventions. She has educated herself in motivational interviewing and venepuncture and believes these are essential skills of the ever expanding psychiatric nurse’s clinical skill repertoire. She recently completed a professional certificate in RCSI and is now a Registered Nurse Prescriber. She is very excited about the future of prescribing & treatment options available in the area of physical health and antipsychotic induced weight gain
Ms. Shelley Crawford
Ms. Shelley Crawford
Coaching Psychologist
A dynamic leader and wellbeing facilitator, Shelley has in-depth and specialist knowledge in leadership and team individual health and wellbeing programmes. Her creative design skills result in interactive and engaging programme material, tools and workshops underpinned by solid research. A European Mentoring and Coaching Council (EMCC) Global accredited Master Coach, EMCC accredited Supervisor & Assessor, and Organisational and Coaching Psychologist, Shelley has worked with global leaders and teams from a diverse range of cultures, disciplines & levels. Organisations she has worked with in Ireland, UK, UAE and Europe include: Irish Life, HSE, Keywords, Google, Twitter, Tik-Tok, Salesforce, Munster Technological University, Irish Management Institute, University College Cork, Johnson & Johnson, Janssen, Red Hat, Element 6, IBM, Takeda, Mediolanum, Primary Health Care Corporation (Doha) and extensive schools and colleges in Ireland. Her research, methodologies, processes and tools are aligned with international Coaching and Mentoring Competence Frameworks and the Global Code of Ethics. As an EMCC Accredited Master Coach, Shelley undertakes a minimum of 16 hours of discipline specific CPD per annum, in line with standards laid down by professional associations. As the Head of EMCC’s Global Quality Award Accreditation Assessor team and Quality Award Programme accreditation assessment, Shelley advises and manages small and large-scale programme accreditation projects. As part of this role, she leads a team of global programme assessors and liaises with a diverse range of stakeholders globally, supporting and advising them on programme design and rollout. Shelley is the creator of the Jess© Resilience-building 1.0 and 2.0 model (2017, 2023) and the Tess© Trust-building (2023) and Retro-trust building (2024) models and tools. Shelley first presented her resilience-building model to the International EMCC Conference in Edinburgh (2017). She has since written Resilience-building for Practitioners: The Jess© Model book, a Positive Psychology book chapter on Rumination, and a number of research articles related to resilience-building and trust-building in teams.

Date

16 May 2025
Expired!

Time

10:00 am - 2:45 pm

Location

Midlands Park Hotel
Portlaoise, Co.Laois

Organizer

Lundbeck
Lundbeck
Phone
+353 87 9680242
Email
info@cpdsessions.com

Speakers

  • Mr Michael Hevey
    Mr Michael Hevey Advanced Nurse Practitioner
    Mr Michael Hevey
    Mr Michael Hevey
    Advanced Nurse Practitioner

    Michael Hevey is an Advanced Nurse Practitioner in Inclusion Mental Health at Dublin South City Mental Health Service/ St. James’s Hospital. Inclusion Health is a relatively modern term used to identify people who have traditionally been socially excluded from mainstream healthcare and have experienced factors that have contributed to poor health, such as poverty, violence, and complex trauma (Luchenski et al. 2018). Most often, those excluded are homeless people, individuals with drug and alcohol addiction, members of Traveller, Roma and Gypsy communities, sex workers, migrant populations, people who have been trafficked for slavery, people who have had contact with the criminal justice system, and members of the LGBTQ+ community.

    Prior to his appointment to the ANP in 2023, Michael has served as a Community Mental Health Nurse since 2001 within the Dublin South Central Mental Health Service. He finalized his psychiatric nursing training at St. Patrick’s Hospital in 1995 and subsequently earned a Bachelor of Arts in Industrial Relations and Personnel Management from the National College of Ireland in 2003. Michael attained a Master of Science degree in Nursing (Applied Healthcare Management) from University College Dublin in 2011. In 2018, he graduated with a Professional Diploma in Prescription of Medication from University College Dublin, and in 2019, he completed the Graduate Certificate in Advanced Nursing Practice, also from University College Dublin.

    In 2022, Michael, together with Dr. Eileen Sweeney, Consultant Psychiatrist at the DSCMHS, and Professor Ní Cheallaigh, established the Inclusion Health Research Forum at St. James’s Hospital. This initiative aims to bring together clinicians and academics from the Hospital, as well as other healthcare providers and educational institutions.

    Michael serves as a preceptor for undergraduate nursing students during their clinical placements. Additionally, he delivers lectures to both undergraduate nursing and medical students, as well as graduate nursing students at University College Dublin and Trinity College Dublin.

    In 2020, Michael was appointed as an Adjunct Lecturer/ Assistant Professor at the University College Dublin School of Nursing, Midwifery, and Health Systems (UCDSNMHS). In this capacity, he actively participates in the education of both undergraduate and postgraduate students. A significant aspect of his responsibilities at UCDSNMHS involves facilitating student workshops on the Advanced Health Assessment Module, Integrated Care Module, Clinical Decision-Making Module, and Clinical Practicum Module.

    Michael began his doctoral studies at UCDSNMHS in January 2022 and was awarded a PhD scholarship in September 2022.

    In August 2022, Michael presented at the ICN Nurse Practitioners/Advanced Nurse Practitioner Conference on student Nurse Practitioners’ perceptions of fundamental care. In September of the same year, he presented at the Nursing & Midwifery Planning & Development Unit Dublin South, Kildare, and Wicklow’s 7th Annual Regional Conference on ‘Inclusion Health Nurses—Overcoming Barriers’.

    Michael was a keynote speaker at a conference in Lisbon in 2023 on ‘Community Mental Health Care in Ireland—Evolving Nursing Roles’ at the Seminário de Enfermagem de Saúde Mental: Lisboa.

    In 2024, Michael presented at the Dublin and Midlands Nursing and Midwifery Conference, where he won the award for Best Oral Presentation for his talk on establishing and developing an Advanced Nurse Practitioner role in Inclusion Mental Health.

  • Ms. Elizabeth Wycherley
    Ms. Elizabeth Wycherley Advanced Nurse Practitioner
    Ms. Elizabeth Wycherley
    Ms. Elizabeth Wycherley
    Advanced Nurse Practitioner

    Elizabeth Wycherley is a Registered Advanced Nurse Practitioner in Early Intervention in Psychosis since 2019. She was a driving force in the initiation of an Early Intervention in Psychosis service in North Lee Mental Health Service in Cork, established in 2012. Elizabeth is now working with the RISE Team, one of the National Clinical Programmes Demonstration Sites in South Lee Mental Health Services also in Cork.

  • Ms. Helen Cocoman
    Ms. Helen Cocoman Advanced Nurse Practitioner (cand)
    Ms. Helen Cocoman
    Ms. Helen Cocoman
    Advanced Nurse Practitioner (cand)

    Helen trained in Trinity College Dublin, she qualified as Registered Psychiatric Nurse in 2008. She worked in Acute/Community and Rural outback of Australia caring for multicultural mental health patients. She returned to Ireland in 2015 and worked in inpatient and adult community mental teams as an A/CNS. She completed a post graduate diploma in University of Limerick. She then worked as CNS in physical health in the Kildare mental health service and now is a candidate Advanced Nurse Practitioner in Physical Health in Tallaght mental health services. She has always had a strong passion for the physical health of our mental health patients and making every contact count in her nursing assessments & interventions. She has educated herself in motivational interviewing and venepuncture and believes these are essential skills of the ever expanding psychiatric nurse’s clinical skill repertoire. She recently completed a professional certificate in RCSI and is now a Registered Nurse Prescriber. She is very excited about the future of prescribing & treatment options available in the area of physical health and antipsychotic induced weight gain

  • Ms. Shelley Crawford
    Ms. Shelley Crawford Coaching Psychologist
    Ms. Shelley Crawford
    Ms. Shelley Crawford
    Coaching Psychologist

    A dynamic leader and wellbeing facilitator, Shelley has in-depth and specialist knowledge in leadership and team individual health and wellbeing programmes. Her creative design skills result in interactive and engaging programme material, tools and workshops underpinned by solid research.

    A European Mentoring and Coaching Council (EMCC) Global accredited Master Coach, EMCC accredited Supervisor & Assessor, and Organisational and Coaching Psychologist, Shelley has worked with global leaders and teams from a diverse range of cultures, disciplines & levels.

    Organisations she has worked with in Ireland, UK, UAE and Europe include: Irish Life, HSE, Keywords, Google, Twitter, Tik-Tok, Salesforce, Munster Technological University, Irish Management Institute, University College Cork, Johnson & Johnson, Janssen, Red Hat, Element 6, IBM, Takeda, Mediolanum, Primary Health Care Corporation (Doha) and extensive schools and colleges in Ireland.

    Her research, methodologies, processes and tools are aligned with international Coaching and Mentoring Competence Frameworks and the Global Code of Ethics. As an EMCC Accredited Master Coach, Shelley undertakes a minimum of 16 hours of discipline specific CPD per annum, in line with standards laid down by professional associations.
    As the Head of EMCC’s Global Quality Award Accreditation Assessor team and Quality Award Programme accreditation assessment, Shelley advises and manages small and large-scale programme accreditation projects. As part of this role, she leads a team of global programme assessors and liaises with a diverse range of stakeholders globally, supporting and advising them on programme design and rollout.

    Shelley is the creator of the Jess© Resilience-building 1.0 and 2.0 model (2017, 2023) and the Tess© Trust-building (2023) and Retro-trust building (2024) models and tools. Shelley first presented her resilience-building model to the International EMCC Conference in Edinburgh (2017). She has since written Resilience-building for Practitioners: The Jess© Model book, a Positive Psychology book chapter on Rumination, and a number of research articles related to resilience-building and trust-building in teams.

  • Ms. SInead Fahy
    Ms. SInead Fahy Community Mental Health Nurse
    Ms. SInead Fahy
    Ms. SInead Fahy
    Community Mental Health Nurse

    Sinead Fahy McCarthy is a dedicated and highly experienced psychiatric nurse with over two decades of expertise in mental health care. She began her professional journey in 2002 after successfully training and qualifying as a psychiatric nurse. Her early career saw her working in rehabilitation units, where she provided essential support to individuals undergoing long-term recovery. In 2003, she transitioned to acute mental health units, gaining extensive experience working with adults in both male and female wards, dealing with complex and acute psychiatric conditions.

    In 2004, Sinead took a pivotal step in her career by moving into community-based mental health services. She played a key role in the establishment of the first Home-Based Treatment Team in Tallaght, working alongside colleagues to develop an alternative to hospital admissions for individuals in crisis. This innovative approach focused on providing intensive, short-term interventions in a patient’s home environment, promoting stability and recovery while reducing the need for inpatient care.

    Throughout her career, Sinead has continuously pursued professional development to enhance her expertise. In 2009, she completed a specialized course on eating disorders at the University of Ulster, expanding her knowledge of the complexities surrounding these conditions. Recognizing the importance of evidence-based therapies, she obtained a Certificate in Cognitive Behavioural Therapy (CBT) through the Health Service Executive (HSE), equipping her with the skills to provide structured psychological interventions to those experiencing anxiety, depression, and other mental health challenges. In 2014, she furthered her qualifications by completing a Nurse Prescribing Course with the Royal College of Surgeons in Ireland (RCSI), allowing her to take on an advanced role in medication management within psychiatric care.

    Committed to continuous learning and the integration of cutting-edge psychological approaches, Sinead is currently undertaking a course in Coaching and Neuroscience. This additional training is aimed at broadening her expertise in mental health support, leadership, and personal development, reinforcing her holistic approach to patient care.

    Sinead’s professional journey reflects her deep passion for mental health nursing, her commitment to patient-centered care, and her dedication to advancing the field through ongoing education and innovation.